Citation: Ajg. Ordonez et al., Risk of venous thromboembolism associated with the insertion/deletion polymorphism in the angiotensin-converting enzyme gene, BL COAG FIB, 11(5), 2000, pp. 485-490
Citation: Ajg. Ordonez et al., Two expressive polymorphisms on the endothelial nitric oxide synthase gene(intron4, 27 bp repeat and-786 T/C) and the venous thromboembolism, THROMB RES, 99(6), 2000, pp. 563-566
Citation: Ajg. Ordonez et al., Lowering high levels of fasting total homocysteine with folic acid and vitamins B in patients with venous thromboembolism: relationship between response and the C677T methylenetetrahydrofolate reductase (MTHFR) genotype, MED CLIN, 114(1), 2000, pp. 7-12
Citation: Ajg. Ordonez et al., A high factor II/factor X functional ratio is not a useful predictor of the FII G20210A gene mutation in thromboembolic patients undergoing oral anticoagulant treatment, CLIN CHEM, 46(6), 2000, pp. 886-887
Citation: Ajg. Ordonez et al., Genetic polymorphism of methylenetetrahydrofolate reductase and venous thromboembolism: a case-control study, HAEMATOLOG, 84(2), 1999, pp. 190-191
Citation: Ec. Garcia et al., Young female with low grade fever and pain over the left hypochondrium of two months' duration, REV CLIN ES, 199(2), 1999, pp. 105-106
Citation: Ajg. Ordonez et al., A patient homozygous for mutation 20210 A in the prothrombin gene with venous thrombosis and transient ischemic attacks of thrombotic origin, HAEMATOLOG, 83(11), 1998, pp. 1050-1051